Results 81 to 90 of about 8,176 (156)

Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy. [PDF]

Hepatol Commun
Jesudian AB, Gagnon-Sanschagrin P, Bungay R, Easson K, Bellefleur R, Guérin A, Shah SK, Olujohungbe O.   +7 more
europepmc   +1 more source

Risk-stratified pharmacologic strategies for secondary prevention after acute diverticulitis: an exploratory narrative review and research framework. [PDF]

Front Surg
Schiano di Visconte M, Sarnari S, Lo Monaco D, Brillantino A, Marano L, Talento P, Guttadauro A.   +6 more
europepmc   +1 more source

Intestinal decontamination with rifaximin attenuates LSEC dysfunction and liver fibrosis in mice. [PDF]

PLoS One
Su T, Lai S, Chen H.
europepmc   +1 more source

A Novel Use of Tenapanor in Patients With Hepatic Encephalopathy: A Case Series. [PDF]

ACG Case Rep J
Yeo YH, Ayoub W, Rezaie A.
europepmc   +1 more source

Diarrhea management: from pathophysiology to microbiota modulation. [PDF]

Ther Adv Gastroenterol
Marasco G, Meacci D, Sarnelli G, Tosetti C, Cremon C, Savarino EV, Barbara G.   +6 more
europepmc   +1 more source

Recurrent Hepatic Encephalopathy After Abdominal Surgery in a Non-Cirrhotic Patient: A Case Report. [PDF]

Reports (MDPI)
Ziola S, Cittadini G, Pasta A, Labanca S, Pieri G, Marenco S, Giannini EG.   +6 more
europepmc   +1 more source

Clinical Challenges in the Management of Hepatic Encephalopathy in Older Patients with Cirrhosis: A Nationwide Italian Physician-Reported Survey. [PDF]

Medicina (Kaunas)
Lapenna L, Di Cola S, Nardelli S, Merli M.   +3 more
europepmc   +1 more source

Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin. [PDF]

Nat Commun
Kuo CH, Carter GP, Howden BP, Huang TW, Cao Z, Yeo YH, Wu CY.   +6 more
europepmc   +1 more source

Milk Disposition Kinetics, Residue and Efficacy of Rifaximin After Intramammary Administration in Lactating Cow. [PDF]

Antibiotics (Basel)
Yu N, Tang Y, Zhao W, Xiang J, Qu J, Wu H, Liu Y.   +6 more
europepmc   +1 more source

Rifaximin improves anxiety- and depression-like behaviors in rats by regulating NPY in the colon and mPFC. [PDF]

Sci Rep
Luo Q, Li H, Wang Y, Liu D, Ho CSH.
europepmc   +1 more source